1. SPTLC2 variants are associated with early‐onset ALS and FTD due to aberrant sphingolipid synthesis.
- Author
-
Naruse, Hiroya, Ishiura, Hiroyuki, Esaki, Kayoko, Mitsui, Jun, Satake, Wataru, Greimel, Peter, Shingai, Nanoka, Machino, Yuka, Kokubo, Yasumasa, Hamaguchi, Hirotoshi, Oda, Tetsuya, Ikkaku, Tomoko, Yokota, Ichiro, Takahashi, Yuji, Suzuki, Yuta, Matsukawa, Takashi, Goto, Jun, Koh, Kishin, Takiyama, Yoshihisa, and Morishita, Shinichi
- Subjects
AMYOTROPHIC lateral sclerosis ,GENETIC variation ,FRONTOTEMPORAL dementia ,RILUZOLE ,PROTEIN structure ,ETIOLOGY of diseases ,FRONTOTEMPORAL lobar degeneration ,ACID-base imbalances - Abstract
Objective: Amyotrophic lateral sclerosis (ALS) is a devastating, incurable neurodegenerative disease. A subset of ALS patients manifests with early‐onset and complex clinical phenotypes. We aimed to elucidate the genetic basis of these cases to enhance our understanding of disease etiology and facilitate the development of targeted therapies. Methods: Our research commenced with an in‐depth genetic and biochemical investigation of two specific families, each with a member diagnosed with early‐onset ALS (onset age of <40 years). This involved whole‐exome sequencing, trio analysis, protein structure analysis, and sphingolipid measurements. Subsequently, we expanded our analysis to 62 probands with early‐onset ALS and further included 440 patients with adult‐onset ALS and 1163 healthy controls to assess the prevalence of identified genetic variants. Results: We identified heterozygous variants in the serine palmitoyltransferase long chain base subunit 2 (SPTLC2) gene in patients with early‐onset ALS. These variants, located in a region closely adjacent to ORMDL3, bear similarities to SPTLC1 variants previously implicated in early‐onset ALS. Patients with ALS carrying these SPTLC2 variants displayed elevated plasma ceramide levels, indicative of increased serine palmitoyltransferase (SPT) activity leading to sphingolipid overproduction. Interpretation: Our study revealed novel SPTLC2 variants in patients with early‐onset ALS exhibiting frontotemporal dementia. The combination of genetic evidence and the observed elevation in plasma ceramide levels establishes a crucial link between dysregulated sphingolipid metabolism and ALS pathogenesis. These findings expand our understanding of ALS's genetic diversity and highlight the distinct roles of gene defects within SPT subunits in its development. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF